Skip to content

Impact of Belt Position on the Results of PEEP Titration by EIT During ARDS

Impact of Belt Position on the Results of PEEP Titration by Electrical Impedance Tomography During Acute Respiratory Distress Syndrome

Status
Not yet recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06541522
Acronym
REPEIT
Enrollment
20
Registered
2024-08-07
Start date
2025-01-01
Completion date
2026-01-31
Last updated
2024-11-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

ARDS

Keywords

ARDS, mechanical ventilation, EIT

Brief summary

ARDS is a frequent reason for hospitalization in intensive care. In order to improve its management, doctors seek to limit the mechanical ventilation-induced injuries (VILI) that can occur. PEEP is a parameter that plays a role in the appearance of VILI, and its adjustment can be optimized by EIT. The EIT is a non-invasive, non-irradiating, real-time monitoring device, today widely used for the optimization of ventilation in patients intubated for ARDS. The positioning of the EIT belt at different chest heights could influence the result of the PEEP titration.

Detailed description

The aim of this study is to test the hypothesis that the position (2nd intercostal space or 5th intercostal space) of the EIT (Electrical Impedance Tomography) belt significantly influences the result of PEEP (Positive Expiratory Pressure) titration.

Interventions

DEVICEEIT

Two PEEP titrations monitored by EIT will be performed, each with the electrode belt positioned at a different chest height (2nd intercostal space or 5th intercostal space). The order will be drawn at random.

Sponsors

Centre Hospitalier Saint Joseph Saint Luc de Lyon
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
OTHER
Masking
NONE

Intervention model description

Once the patient is included in the research, two PEEP titrations monitored by EIT will be performed, each with the electrode belt positioned at a different chest height. The order will be drawn at random.

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Occurrence of moderate to severe ARDS (PaO2/FiO2 ratio ≤ 200 mmHg) within 72 hours following intubation * Criteria for moderate to severe ARDS for less than 72 hours * Passive ventilation in controlled assisted ventilation (no spontaneous ventilation) * Consent of next of kin

Exclusion criteria

* Age \< 18 years * ECMO * Pneumothorax * Pacemaker or implantable defibrillator * Chest trauma in the last 3 months * Skin peeling (Burned, Lyell) * Intracranial hypertension * Uncontrolled shock (noradrenaline \>5 mg/h) * Pregnant woman * Adult patient protected within the meaning of the law * Lack of social security

Design outcomes

Primary

MeasureTime frameDescription
Impact of the position of the electrode belt on the results of PEEP titration by EIT.Day 0Optimal PEEP determined by PEEP titration using the crossing point method.

Secondary

MeasureTime frameDescription
Impact of the existence of intra-tidal recruitment on the discordance between PEPEIT and PEPCRSDay 0Variability of the impedance variation during insufflation of the tidal volume (tidal impedance variation) during titration measured by the relative interquartile coefficient (Q3-Q1)/median
Factors associated with a discordance between PEPEIT and PEPCRSDay 0Variability of the impedance variation during insufflation of the tidal volume (tidal impedance variation) during titration measured by the relative interquartile coefficient (Q3-Q1)/median
Discrepancy between compliance measured according to impedance and compliance measured according to exhaled volumeDay 0Regional ventilation delay (RVD)

Contacts

Primary ContactSamuel Tuffet, MD
stuffet@saintjosephsaintluc.fr+33(0)478618209
Backup ContactFanny Doroszewski, Mrs
fdoroszewski@saintjosephsaintluc.fr+33(0)478618398

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026